AARON CLAYSON: Open Payments
NPI 1629814892 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$102 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $102
Food & beverage: $102
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $15 |
Products named: Rybelsus, TARPEYO, VOYXACT, TAVNEOS.
Industry payments across ID — which companies pay providers there.
